Therapy with ticagrelor/prasugrel is associated with enhanced fibrinolysis and suppressed platelet activation as compared to clopidogrel in chronic coronary syndrome.
- Resource Type
- Article
- Source
- Polish Heart Journal / Kardiologia Polska; 2023, Vol. 81 Issue 11, p1130-1133, 4p
- Subject
- Language
- ISSN
- 00229032